Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.
CONCLUSION: The proper treatment of pleural effusion can be determined only after meticulous differential diagnosis. The range of therapeutic options has recently become much wider. More data can be expected in the near future concerning diagnostic test- ing for the etiology of the effusion, better pleurodetic agents, the development of interventional techniques, and the genetic background of the affected patients. PMID: 31315808 [PubMed - in process]
Lab Chip, 2020, Accepted Manuscript DOI: 10.1039/D0LC00361A, PaperZhixing Ge, Junhua Zhao, Haibo Yu, Wenguang Yang, Peilin Zhou, Zhenning Wang, Lianqing Liu Currently, the mechanisms underlying the peritoneal metastasis of gastric cancer cells and the function of mesothelial cells during this process are unclear, primarily due to the absence of an effective... The content of this RSS Feed (c) The Royal Society of Chemistry
Chem. Commun., 2020, Advance Article DOI: 10.1039/D0CC03614E, CommunicationWentao Zhang, Hyunjun Choi, Bo Yu, Dong-Hyun Kim Iron oxide nanocube patched Janus magnetic porous silica nanocarriers are synthesized and it is expected to be used for a new type of multifunctional carriers in image guided cancer therapeutic applications. To cite this article before page numbers are assigned, use the DOI form of citation above. The content of this RSS Feed (c) The Royal Society of Chemistry
NIEHS grantees study pet dogs to better understand how human exposure to everyday chemicals may lead to cancer and other conditions. (read more)
New findings from the Agricultural Health Study suggest exposure to certain pesticides may increase risk of renal cell carcinoma. (read more)
NIEHS and Canadian scientists discover that cancer cells with mutated BRCA1 and BRCA2 genes died when they lacked a protein called APE2. (read more)
Publication date: Available online 5 July 2020Source: Genes &DiseasesAuthor(s): Xi Liu, Jimin Xu, Jia Zhou, Qiang Shen
The family name of the corresponding author on the original version of this article was incorrectly spelled as “Mariana Philipos”.
Have you guys ever had a patient in their 40s, rich family history of breast and ovarian cancer, tested positive for the mutation, but does not want any prophylactic surgery. How would you proceed with surveillance? Obviously routine mammography is needed. Would this be an indication for routine pelvic ultrasound (q 1 year)? I read somewhere that sometimes CA 125 is checked as well? (Though i thought tumor markers were more relevant in post diagnosis and prognostic situations)
ConclusionsT2W breast MRI with complete FOV of the axillary region has comparable diagnostic performance as T2W dedicated axillary MRI regarding assessment of node-negative and node-positive breast cancer. Optimization of T2W breast MRI protocol by including a complete FOV of the axillary region can, therefore, be recommended in clinical prac tice.Key Points• Breast MRI with complete field of view of the axillary region has comparable diagnostic performance as dedicated axillary MRI regarding assessment of node-negative and node-positive breast cancer.• Optimization of breast MRI protocol by including ...
Spending less time in REM sleep is linked to a greater overall risk of death from any cause as well as from cardiovascular disease and other diseases except for cancer, a new study finds.